Targeting Liver Cancer Stem Cells: An Alternative Therapeutic Approach for Liver Cancer
Open Access
Abstract
The first report of cancer stem cell (CSC) from Bruce et al. has demonstrated the relatively rare population of stem-like cells in acute myeloid leukemia (AML). The discovery of leukemic CSCs prompted further identification of CSCs in multiple types of solid tumor. Recently, extensive research has attempted to identity CSCs in multiple types of solid tumors in the brain, colon, head and neck, liver, and lung. Based on these studies, we hypothesize that the initiation and progression of most malignant tumors rely largely on the CSC population. Recent studies indicated that stem cell-related markers or signaling pathways, such as aldehyde dehydrogenase (ALDH), CD133, epithelial cell adhesion molecule (EpCAM), Wnt/β-catenin signaling, and Notch signaling, contribute to the initiation and progression of various liver cancer types. Importantly, CSCs are markedly resistant to conventional therapeutic approaches and current targeted therapeutics. Therefore, it is believed that selectively targeting specific markers and/or signaling pathways of hepatic CSCs is an effective therapeutic strategy for treating chemotherapy-resistant liver cancer. Here, we provide an overview of the current knowledge on the hepatic CSC hypothesis and discuss the specific surface markers and critical signaling pathways involved in the development and maintenance of hepatic CSC subpopulations.Keywords
Funding Information
- Korea Centers for Disease Control and Prevention (2019-P6713-00)
This publication has 254 references indexed in Scilit:
- Hepatic transforming growth factor beta gives rise to tumor-initiating cells and promotes liver cancer developmentHepatology, 2012
- Activation of JNK and high expression level of CD133 predict a poor response to sorafenib in hepatocellular carcinomaBritish Journal of Cancer, 2012
- Overexpression of Thy1/CD90 in human hepatocellular carcinoma is associated with HBV infection and poor prognosisActa Histochemica, 2011
- TGF-β in progression of liver diseaseCell and tissue research, 2011
- The critical role of CD133+CD44+/high tumor cells in hematogenous metastasis of liver cancersCell Research, 2011
- Viral factors induce Hedgehog pathway activation in humans with viral hepatitis, cirrhosis, and hepatocellular carcinomaLaboratory Investigation, 2010
- Hepatocellular cancer arises from loss of transforming growth factor beta signaling adaptor protein embryonic liver fodrin through abnormal angiogenesis†Hepatology, 2008
- The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem CellsCell, 2008
- Wnt/β-catenin signaling: new (and old) players and new insightsCurrent Opinion in Cell Biology, 2008
- Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined FactorsCell, 2007